U.S. researchers are aiming to inventory the DNA of every living thing on a French Polynesian island. [ + ]

French toxinologist, Pierre Escoubas, is finding interesting pharmacology in the venoms of smaller species that punch way above their weight. [ + ]

Sonic Healthcare (ASX:SHL) continues its expansion strategy in the U.S. [ + ]

Phase III trial for MoxDuo IR in the U.S. with final trial to begin in 2010. [ + ]

Women are significantly less likely to recieve major funding for scientific research in the US, according to a University of Michigan study.

Commercialisation Australia will supersede the Commercialising Emerging Technologies program and will introduce a new, simpler form of assistance to companies seeking to take their ideas to market.

Submissions now open for Federal Government's Clinical Trials Action Group. [ + ]

Senate inquiry on gene patents now to report in March 2010. [ + ]

The Clinical Trials Action Group is seeking public input into ways it can assist in enhancing Australia as a preferred destination for clinical trials.

The study of patenting and licensing trends in climate change reveal global inequities which could be addressed through improved policymaking.

Thermo Fisher Scientific product lines, including Nalgene, Nunc, Shandon, Finnpippette, Molecular Bio Products (MBP), Matrix, Revco, Heraeus, Sorvall, ABgene, Pierce and Hyclone, as well as the Fisher Chemicals, Maybridge and Acros Organics, will now be available for direct purchase in Australia and New Zealand.

Prima BioMed, QRxPHarma, Sirtex Medical, Primary Health Care, ResMed, Cochlear [ + ]

Australian scientists develop rapid and easy assay that could lead to a new cancer tests and targeted chemotherapy drugs. [ + ]

Lung function test recommended for approval for us in the U.S. by FDA Pulmonary-Allergy Drugs Advisory Committee. [ + ]

Researchers unravel the evolutionary history of box jellyfish, gaining insight in to new antivenoms and treatments. [ + ]